<
Sichuan Chinese Pharmaceutical Company abandoned the European Union market to focus on Southeast Asia
Release time: 2011-04-19 & nbsp & nbsp & nbsp Source:
Business Club, April 19th, a botanical medicine market up to 5 billion euros,Chinese companies are facing difficulties that will be rejected。According to the EU regulations,Selling and using traditional plant medicines in the EU,It must be completed in the EU before April 30, 2011,"As of now,Including Sichuan inside,No Chinese medicine company in China passes registration in the European Union,Liu stake online sports bettingStake Sports BettingZhanglin, vice chairman of the Import and Export Chamber of Commerce of China Medical Health Products, told reporters from Chengdu Business Daily。
 
As a major production province for Chinese medicinal materials and its finished products,The reporter learned from a number of enterprises with Chinese medicine and Chinese medicine in Sichuan yesterday.,Because the threshold of the EU is too high,Sichuan companies basically abandon this cake,Gradually withdrew from the EU market。
 
The cost of the EU market is too high
 
EU is one of the world's largest plant drug markets。but,2004,EU issued the "Traditional Botanical Registration Procedures" regulations,All botanical drug manufacturers must complete the registration before April 30, 2011,Otherwise, it is not allowed to be sold and used in the European Union。
 
Liu Zhanglin told reporters yesterday,"Due to multiple reasons,As of now, no company has passed this registration。"Liu Zhanglin said,Since last year,Several companies in China have tried to register,But I didn’t pass it。Liu Zhanglin analysis said,The first is that the registration cost is too high。According to regulations,The single registration cost of Chinese patent medicine is about 1 million yuan,and a Chinese stake online sports bettingStake Sports Bettingmedicine company generally has multiple varieties; the second is that the EU's registration requirements are higher。Regulations,Traditional herbal medicine "has at least 30 years of medicinal history for at least 30 years before the application day,Among them, at least 15 years of use in the European Union "。
 
Yesterday,Several Chinese medicine companies in Sichuan who are engaged in Chinese medicine and Chinese medicine slices in Sichuan told reporters,"The current registered interest is not much",China's first Chinese medicine tablet GMP factory、Deputy General Manager of Sichuan Xinhe Company Xiong Shichao said yesterday,"Mainly the registration cost is too high,Cost severely limited the efficiency of the enterprise。”
 
Sichuan enterprise concentrated exports to Southeast Asia
 
Chengdu Business Daily reporter learned,Affected by the threshold of registered regulations,Sichuan Chinese medicine companies have been forced to evacuate the EU market in recent years。Sichuan Xinhe Company's export amount is among the best among Sichuan Chinese medicine companies,Its deputy general manager Xiong Shichao said,Former related products exported to Germany,Sales of the highest peak period can reach 1 million yuan per month,But now "I haven'stake sports betting appstake sports betting appt done it for more than a year。"As for the reason for the EU,Xiong Shichao said,Mainly the threshold is too high,Can't make money。His analysis says,"A single variety registration requires 1 million yuan,General enterprises have multiple varieties,The registration cost exceeds the sales of many Sichuan enterprises。”
 
Sichuan Xiangyun Traditional Chinese Medicine Drinking and Export Co., Ltd. was founded in 1993,It is one of the earliest companies that have obtained import and export qualification certificates in the traditional Chinese medicine beverage industry,The person in charge of Zhang Zhang said to reporters,"Now basically no sales business in the European Union",For the EU market,The person sighs,"The threshold is too high,The cost is too large。”
 
The reporter also learned,Sichuan's interest in the EU market is not much interesting。Assistant General Manager of Sichuan Province Keli Traditional Chinese Medicine Co., Ltd. yesterday told reporters,Compared to the Southeast Asian market,The risk of the EU market is greater。Related companies,Due to the small proportion of sales in the EU market, the proportion of total exports is small,The largest company is only about 20%,EU regulations have Stake Sports Bettingno stake sports betting appimpact on Sichuan companies。Southeast Asia's market threshold is low,and high acceptance of Chinese medicine,Related persons said that Sichuan companies are currently exported to Southeast Asia。(Xi Dawei)